Brief: Galectin Therapeutics Qtrly Loss Per Share $0.14
15/11/2021 13:52
Nov 15 (Reuters) - Galectin Therapeutics Inc GALT.O :
* GALECTIN THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.14
* GALECTIN- BELIEVES IT HAS SUFFICIENT CASH TO FUND
CURRENTLY
PLANNED OPERATIONS & RESEARCH AND DEVELOPMENT ACTIVITIES THROUGH
AT LEAST MARCH 31, 2023
Source text for Eikon: ID:
Further company coverage: GALT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Galectin Therapeutics
See all newsGalectin Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Galectin Therapeutics Reports June 30, 2026 Financial Results
Galectin Therapeutics Q2 loss widens
Galectin Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Galectin Therapeutics rises as FDA clears path for late-stage liver drug study